• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Percutaneous coronary intervention with peripheral artery disease in the contemporary era: Still life or limb?

作者信息

Kumar Rajesh, Bainey Kevin R

机构信息

Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada.

Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada.

出版信息

Atherosclerosis. 2022 Aug;355:45-47. doi: 10.1016/j.atherosclerosis.2022.06.1022. Epub 2022 Jul 3.

DOI:10.1016/j.atherosclerosis.2022.06.1022
PMID:35817601
Abstract
摘要

相似文献

1
Percutaneous coronary intervention with peripheral artery disease in the contemporary era: Still life or limb?当代经皮冠状动脉介入治疗合并外周动脉疾病：是挽救生命还是保住肢体？
Atherosclerosis. 2022 Aug;355:45-47. doi: 10.1016/j.atherosclerosis.2022.06.1022. Epub 2022 Jul 3.
2
ABC as in Arteriopathy, Bleeding, and Coronary disease: Disentangling the prognostic conundrum of patients undergoing percutaneous coronary intervention with concomitant peripheral artery disease.ABC代表动脉病变、出血和冠状动脉疾病：解析接受经皮冠状动脉介入治疗并伴有外周动脉疾病患者的预后难题。
Catheter Cardiovasc Interv. 2024 Mar;103(4):686-687. doi: 10.1002/ccd.30982. Epub 2024 Feb 22.
3
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.替卡格雷与氯吡格雷在有症状外周动脉疾病和既往冠状动脉疾病患者中的比较：来自 EUCLID 试验的结果。
Vasc Med. 2018 Dec;23(6):523-530. doi: 10.1177/1358863X18775594. Epub 2018 Jul 11.
4
Differences in risk factors and resource utilization for women undergoing percutaneous coronary intervention and lower extremity peripheral vascular intervention.行经皮冠状动脉介入治疗和下肢外周血管介入治疗的女性患者的危险因素和资源利用的差异。
Catheter Cardiovasc Interv. 2020 Jul;96(1):136-142. doi: 10.1002/ccd.28431. Epub 2019 Aug 9.
5
Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials.伴发外周动脉疾病患者行经皮冠状动脉介入治疗应用当代支架的预后：四项随机试验的患者水平汇总分析。
Atherosclerosis. 2022 Aug;355:52-59. doi: 10.1016/j.atherosclerosis.2022.05.002. Epub 2022 May 20.
6
Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.左主干疾病的经皮冠状动脉介入治疗：EXCEL（评价依维莫司洗脱支架 XIENCE 与冠状动脉旁路移植术治疗左主干血运重建效果）和 NOBLE（北欧-波罗的海-英国左主干血运重建研究）时代之前和之后。
Circ Cardiovasc Interv. 2017 Jun;10(6). doi: 10.1161/CIRCINTERVENTIONS.117.004792.
7
Comparison of collagen-based vascular closure devices in patients with vs. without severe peripheral artery disease.患有与未患有严重外周动脉疾病的患者使用基于胶原蛋白的血管闭合装置的比较。
J Endovasc Ther. 2014 Feb;21(1):79-84. doi: 10.1583/13-4401MR.1.
8
Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives.用于心血管应用的生物可吸收金属支架：当前认知与未来展望。
Cardiovasc Revasc Med. 2014 Mar;15(2):109-16. doi: 10.1016/j.carrev.2014.01.011. Epub 2014 Jan 30.
9
Meta-analysis of three randomized controlled trials comparing coronary artery bypass grafting with percutaneous coronary intervention using drug-eluting stenting in patients with diabetes.三项随机对照试验的荟萃分析：比较糖尿病患者冠状动脉搭桥术与使用药物洗脱支架的经皮冠状动脉介入治疗。
Interact Cardiovasc Thorac Surg. 2014 Dec;19(6):1002-7. doi: 10.1093/icvts/ivu291. Epub 2014 Sep 3.
10
Outcomes and safety of concurrent coronary and peripheral catheterization (REVascularization in concomitant PERIpheral artery disease and coronary artery disease REV-PERICAD Study).同期冠状动脉与外周血管导管插入术的结果及安全性（合并外周动脉疾病和冠状动脉疾病的血运重建REV-PERICAD研究）
Catheter Cardiovasc Interv. 2020 Sep 1;96(3):E317-E323. doi: 10.1002/ccd.28745. Epub 2020 Jan 22.